Yilong Wang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Vascular Endothelial Growth Factor

Ischemia Reperfusion Injury

Protein Protein

Top Venues

Journal of molecular medicine (Berlin, Germany)

Cell death and differentiation

Cell death & disease

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

This page only lists publications with an associated author ORCID identifier.

Publications

Lizhi Zhou, Zebin Deng, Yilong Wang, Hao Zhang, Shu Yan, Yashpal S Kanwar, Yinghuai Wang, Yingbo Dai, Fei Deng
PRMT4 interacts with NCOA4 to inhibit ferritinophagy in cisplatin-induced acute kidney injury. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38 (7) (2024)
Shu Yan, Ji Hu, Jia Li, Pengchao Wang, Yilong Wang, Zhaohui Wang
Correction to: PRMT4 drives post-ischemic angiogenesis via YB1/VEGF signaling. Journal of molecular medicine (Berlin, Germany) (2023)
Jia Li, Cheng-Hui Yan, Yilong Wang, Can Chen, Haibo Yu, Dan Liu, Kai Huang, Ya-Ling Han
GCN5-mediated regulation of pathological cardiac hypertrophy via activation of the TAK1-JNK/p38 signaling pathway. Cell death & disease 13 (4) (2022)
Yilong Wang, Shu Yan, Xuemei Liu, Fei Deng, Pengchao Wang, Liuye Yang, Lizhi Hu, Kai Huang, Jiangui He
PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway. Cell death and differentiation 29 (10) (2022)
Shu Yan, Ji Hu, Jia Li, Pengchao Wang, Yilong Wang, Zhaohui Wang
PRMT4 drives post-ischemic angiogenesis via YB1/VEGF signaling. Journal of molecular medicine (Berlin, Germany) 99 (7) (2021)